Cell and Tissue Preservation Market Size To Gain US$
9.54 Billion By 2030
The cell and tissue preservation market size predicted to from USD 3.95 billion in 2022 to USD 9.54 billion by 2030, growing at a CAGR of 11.6%.
The surging demand for the regenerative medicines owing to the rising prevalence of injuries and agerelated diseases is expected to drive the growth of the cell and tissue preservation market during the forecast period. The growing investments in research and development for the development of new drugs is fueling the market growth.
The rising number of biobanks across the globe is another major factor behind the burgeoning growth of the global cell and tissue preservation market. The surging prevalence of non-communicable diseases such as diabetes, cardiovascular diseases, neurological diseases, and range of various malignancies is positively impacting the market growth across the globe. The rising developments in the software and hardware technologies used in the biobanks and hospitals for preservation of cells and tissues has propelled the demand for the cell and tissue preservation.
Get the sample copy of this report@ https://www.precedenceresearch.com/sample/1642
Report Highlights
• Based on type, the tissue segment dominated the global market in 2022. The rising prevalence of non-communicable diseases, injuries, and age-related diseases among the population is propelling the demand for the cell and tissue preservation to be used in the development of regenerative medicines. Furthermore, the rising demand for the organ transplant is another prominent driver of this segment that has led to the dominance of the tissues segment.
• By application, the therapeutics segment led the global cell and tissue preservation market, accounting for a market share of around 43% in 2022. The rising demand for the cell and tissue preservation in the development of various therapeutics for the treatment of numerous chronic and lifestyle diseases has led to the growth of this segment across the globe.
• Based on the product, the equipment segment dominated the market in 2022. The increased adoption of various equipment among the researchers for conducting research on DNA, plasma,
tissues, and stem cells has propelled the growth of this segment in the past few years.
• By end user, the biobanks segment garnered a revenue share of over 69.5% and dominated the market in 2022. The growing number of biobanks across the globe and the rising penetration of the virtual biobanks has led to the dominance of this segment. The biobanks is also anticipated to be the fastest-growing segment during the forecast period.
Regional Snapshot
North America was the dominant cell and tissue preservation market in 2022. The increased investments in the research, drug discovery, drug development, and in the advancements in the healthcare facilities has fueled the market growth. The higher prevalence of diseases has led to the higher healthcare expenditure and the development of advanced healthcare facilities along with the improved access to it. Furthermore, the presence of several number of biobanks and the rapid emergence of virtual biobanks in the region is expected to further drive the growth of the North America cell and tissue preservation market.
Asia Pacific is projected to grow at the highest CAGR during the forecast period. Asia Pacific is witnessing an increasing investments in the development and growth of the advanced healthcare infrastructure. Furthermore, the growing issues related to pregnancies and gynecological disorders is expected to surge the growth of the cell and tissue preservation market. The declining birth rates in Japan and South Korea owing to the increasing preference for career over marriage, late marriages, and growing women employment. These factors are leading to the complexities in the pregnancies, which is fueling the demand for the services of the fertility clinics and centers. This is expected to drive the growth of the Asia Pacific cell and tissue preservation market in the forthcoming years.
11.6% from 2022 to 2030
Market North America
Fastest Growing Region
Asia Pacific
Base Year 2022
Forecast Year 2022 to 2030
Key Players Thermo Fisher Scientific, Inc., Lonza, BD, MerckKGaA, Cytiva, Agilent Technologies, Inc., Avantor, Inc., FUJIFILM Irvine Scientific, BioLifeSolutions Inc., AMSBIO, Princeton CryoTech, STEMCELL Technologies Inc., LGC SeraCare, Corning Incorporated, CellGenix GmbH and others.
Market Dynamics
Driver
Increasing demand for the regenerative medicines
Regenerative medicines helps to re-grow, replace, and repair the damaged tissues, cells, and organs. The platelet rich plasma and the stem cells used in the regenerative medicines helps to quickly repair the tissues and joints and facilitates quick body healing. The increasing prevalence of various chronic diseases such as cancer, cardiovascular diseases, neurological disorders, severe wounds due to accidents and injuries, and musculoskeletal diseases among the global population along with the rising awareness regarding the benefits of regenerative medicines is expected to drive the growth of the cell and tissue preservation market during the forecast period.
Restraint
High cost of advanced equipment
The costs of acquiring the technologically advanced equipment like freezer, storage, and thawing equipment is high. Furthermore, the adoption of software technology in the cell and tissue preservation is a costly affair. The huge capital investments in the acquisition of this hardware and software technologies is a potential hindering factor of the global cell and tissue preservation market.
Opportunity
Technological innovations in the biomimetic materials
The market players are investing in the adoption of the innovative robots to meet the growing need for automation in the cryopreservation. Certain concentrations of the dimethyl sulfoxide is toxic and can harm the cells and tissues. The companies are heavily investing in the research and development of cryoprotective agents using different combinations of dimethyl sulfoxide with glycerol.
Challenge
Complexities involved in the cell and tissue preservation
There are a lot of challenges and complexities involved in the short term and long term preservation of cells and stems. Furthermore, the use of dimethyl sulfoxide (DMSO) is harmful and toxic to certain cells and tissues, which is a major challenge for the market players to tackle.
Market Segmentation
By Type
• Cell
o Mammalian Cells
o Others (Microorganisms and Plant Cells)
• Tissue
o Blood
o Bone
o Soft Tissues
o Skin
o Others
By Application
• Therapeutics
• Drug Discovery
• Gene therapy
• IVF treatment
• Cell therapy
• Research & Development
By Product
• Equipment
o Freezers
o Refrigerators
o Storage Systems
o Others
• Software
• Bio-preservation Media
o Home-brew Media
o Pre-formulated Media
By End User
• Biobanks
• Hospitals
By Cell Provider
• CD34+
• CD19+
• MSC
• iPSC
• hESC
• Tumor Cells
• Others
By Geography•
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)
Table of Content
Chapter 1. Introduction
1.1 Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3 Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3 Industry Value Chain Analysis
4.3.1 Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3 Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Cell and Tissue Preservation Market
5.1. COVID-19 Landscape: Cell and Tissue Preservation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3 COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2 Market Restraints
6.1.3 Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2 Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5 Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2 Key Strategies Adopted by Players
7.1.3 Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2 List of Buyers
Chapter 8. Global Cell and Tissue Preservation Market, By Type
8.1. Cell and Tissue Preservation Market, by Type, 2022-2030
8.1.1. Cell
8.1.1.1 Market Revenue and Forecast (2017-2030)
8.1.2. Tissue
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Cell and Tissue Preservation Market, By Application Type
9.1. Cell and Tissue Preservation Market, by Application Type, 2022-2030
9.1.1. Therapeutics
9.1.1.1 Market Revenue and Forecast (2017-2030)
Chapter 10. Global Cell and Tissue Preservation Market, By Product Type
10.1. Cell and Tissue Preservation Market, by Product Type, 2022-2030 10.1.1.
10.1.2.1.
10.1.3.1 Market Revenue and Forecast (2017-2030)
Chapter 11. Global Cell and Tissue Preservation Market, By End User Type
11.1. Cell and Tissue Preservation Market, by End User Type, 2022-2030
11.1.1 Biobanks
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Hospitals
11.1.2.1 Market Revenue and Forecast (2017-2030)
Chapter 12. Global Cell and Tissue Preservation Market, By Cell Provider Type
12.1. Cell and Tissue Preservation Market, by Cell Provider, 2022-2030
12.1.1 CD34+
12.1.1.1 Market Revenue and Forecast (2017-2030)
12.1.2. CD19+
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3 MSC
12.1.3.1 Market Revenue and Forecast (2017-2030)
12.1.4. iPSC
12.1.4.1. Market Revenue and Forecast (2017-2030)
12.1.5 hESC
12.1.5.1. Market Revenue and Forecast (2017-2030)
12.1.6. Tumor Cells
12.1.6.1 Market Revenue and Forecast (2017-2030)
12.1.7. Others
12.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Cell and Tissue Preservation Market, Regional Estimates and Trend Forecast
13.1 North America
13.1.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.2 Market Revenue and Forecast, by Application (2017-2030)
13.1.3 Market Revenue and Forecast, by Product (2017-2030)
13.1.4. Market Revenue and Forecast, by End User (2017-2030)
13.1.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.1.6 U.S.
13.1.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.1.6.3 Market Revenue and Forecast, by Product (2017-2030)
13.1.6.4. Market Revenue and Forecast, by End User (2017-2030)
13.1.7. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.1.8 Rest of North America
13.1.8.1 Market Revenue and Forecast, by Type (2017-2030)
13.1.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.1.8.3. Market Revenue and Forecast, by Product (2017-2030)
13.1.8.4 Market Revenue and Forecast, by End User (2017-2030)
13.1.8.5 Market Revenue and Forecast, by Cell Provider (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.2 Market Revenue and Forecast, by Application (2017-2030)
13.2.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.4. Market Revenue and Forecast, by End User (2017-2030)
13.2.5 Market Revenue and Forecast, by Cell Provider (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.6.2 Market Revenue and Forecast, by Application (2017-2030)
13.2.6.3 Market Revenue and Forecast, by Product (2017-2030)
13.2.7. Market Revenue and Forecast, by End User (2017-2030)
13.2.8 Market Revenue and Forecast, by Cell Provider (2017-2030)
13.2.9 Germany
13.2.9.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.9.3 Market Revenue and Forecast, by Product (2017-2030)
13.2.10. Market Revenue and Forecast, by End User (2017-2030)
13.2.11. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.2.12 France
13.2.12.1. Market Revenue and Forecast, by Type (2017-2030)
13.2.12.2. Market Revenue and Forecast, by Application (2017-2030)
13.2.12.3 Market Revenue and Forecast, by Product (2017-2030)
13.2.12.4 Market Revenue and Forecast, by End User (2017-2030)
13.2.13. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.2.14. Rest of Europe
13.2.14.1 Market Revenue and Forecast, by Type (2017-2030)
13.2.14.2 Market Revenue and Forecast, by Application (2017-2030)
13.2.14.3. Market Revenue and Forecast, by Product (2017-2030)
13.2.14.4. Market Revenue and Forecast, by End User (2017-2030)
13.2.15 Market Revenue and Forecast, by Cell Provider (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.2 Market Revenue and Forecast, by Application (2017-2030)
13.3.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.4. Market Revenue and Forecast, by End User (2017-2030)
13.3.5 Market Revenue and Forecast, by Cell Provider (2017-2030)
13.3.6 India
13.3.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.6.2 Market Revenue and Forecast, by Application (2017-2030)
13.3.6.3 Market Revenue and Forecast, by Product (2017-2030)
13.3.6.4. Market Revenue and Forecast, by End User (2017-2030)
13.3.7. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.3.8 China
13.3.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.8.3 Market Revenue and Forecast, by Product (2017-2030)
13.3.8.4. Market Revenue and Forecast, by End User (2017-2030)
13.3.9. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.3.10 Japan
13.3.10.1 Market Revenue and Forecast, by Type (2017-2030)
13.3.10.2. Market Revenue and Forecast, by Application (2017-2030)
13.3.10.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.10.4 Market Revenue and Forecast, by End User (2017-2030)
13.3.10.5 Market Revenue and Forecast, by Cell Provider (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Type (2017-2030)
13.3.11.2 Market Revenue and Forecast, by Application (2017-2030)
13.3.11.3. Market Revenue and Forecast, by Product (2017-2030)
13.3.11.4. Market Revenue and Forecast, by End User (2017-2030)
13.3.11.5 Market Revenue and Forecast, by Cell Provider (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.2 Market Revenue and Forecast, by Application (2017-2030)
13.4.3 Market Revenue and Forecast, by Product (2017-2030)
13.4.4. Market Revenue and Forecast, by End User (2017-2030)
13.4.5 Market Revenue and Forecast, by Cell Provider (2017-2030)
13.4.6 GCC
13.4.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.6.3 Market Revenue and Forecast, by Product (2017-2030)
13.4.6.4. Market Revenue and Forecast, by End User (2017-2030)
13.4.7. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.4.8 North Africa
13.4.8.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
13.4.8.3 Market Revenue and Forecast, by Product (2017-2030)
13.4.8.4 Market Revenue and Forecast, by End User (2017-2030)
13.4.9. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.4.10. South Africa
13.4.10.1 Market Revenue and Forecast, by Type (2017-2030)
13.4.10.2 Market Revenue and Forecast, by Application (2017-2030)
13.4.10.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.10.4. Market Revenue and Forecast, by End User (2017-2030)
13.4.10.5 Market Revenue and Forecast, by Cell Provider (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Type (2017-2030)
13.4.11.2 Market Revenue and Forecast, by Application (2017-2030)
13.4.11.3. Market Revenue and Forecast, by Product (2017-2030)
13.4.11.4. Market Revenue and Forecast, by End User (2017-2030)
13.4.11.5 Market Revenue and Forecast, by Cell Provider (2017-2030)
13.5 Latin America
13.5.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.2 Market Revenue and Forecast, by Application (2017-2030)
13.5.3 Market Revenue and Forecast, by Product (2017-2030)
13.5.4. Market Revenue and Forecast, by End User (2017-2030)
13.5.5. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.5.6 Brazil
13.5.6.1. Market Revenue and Forecast, by Type (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
13.5.6.3 Market Revenue and Forecast, by Product (2017-2030)
13.5.6.4. Market Revenue and Forecast, by End User (2017-2030)
13.5.7. Market Revenue and Forecast, by Cell Provider (2017-2030)
13.5.8 Rest of LATAM
13.5.8.1
13.5.8.2.
13.5.8.3.
13.5.8.4
13.5.8.5